跳至主要内容
临床试验/CTRI/2021/07/034762
CTRI/2021/07/034762招募中4 期

Effect of dexmedetomidine on neuronal apoptosis markers in patients with subarachnoid haemorrhage undergoing surgery in comparison to placebo: a randomised clinical control trial

AIIMS BHUBANESWAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria will be all patients within 19 to 70 years of age in either sex presenting to this hospital with diagnosis of aneurysmal SAH by clinical and radiological investigations planned for surgical clipping.

排除标准

  • 1)Hemodynamic instability (SBP < 100, HR <60, or on continuous infusion of catecholamines) or arrhythmias at screening
  • Heart failure class III or IV (New York Heart Association)
  • 2)Renal failure
  • 3)Liver failure (serum protein < 3 g/dL and total bilirubin > 5 mg/dL
  • 4)Known or suspected brain death
  • 5)Pregnancy
  • 6)Unable to receive dexmedetomidine within 4 hours of surgery

研究者

相似试验